Drug Shortage Report for ETOPOSIDE INJECTION USP
| Report ID | 33330 |
| Drug Identification Number | 02380935 |
| Brand name | ETOPOSIDE INJECTION USP |
| Common or Proper name | ETOPOSIDE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 25ML VIAL |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2017-12-22 |
| Actual start date | 2017-12-18 |
| Estimated end date | 2018-01-29 |
| Actual end date | 2018-01-26 |
| Shortage status | Resolved |
| Updated date | 2018-01-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-01-29 | French | Compare |
| v6 | 2018-01-29 | English | Compare |
| v5 | 2018-01-08 | French | Compare |
| v4 | 2018-01-08 | English | Compare |
| v3 | 2017-12-23 | English | Compare |
| v2 | 2017-12-15 | French | Compare |
| v1 | 2017-12-15 | English | Compare |
Showing 1 to 7 of 7